semaglutide microneedle patch (DWRX5003)
/ Daewoong Pharma
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
October 01, 2025
Daewoong pushes semaglutide into patches with phase 1 trial launch in Korea
(Korea Biomedical Review)
- "The first-in-human trial will assess safety and pharmacokinetics in healthy adults and measure relative bioavailability against Novo Nordisk’s injectables Ozempic and Wegovy."
New P1 trial • Obesity
1 to 1
Of
1
Go to page
1